Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The FDA has announced a sweeping ban on Red Dye No. 3, giving food companies three years to reformulate their products.

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

Fintel reports that on June 30, 2025, Ascendiant Capital initiated coverage of Aytu BioPharma (NasdaqCM:AYTU) with a Buy recommendation. Analyst Price Forecast Suggests 337.14% Upside As of June 20, ...

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza ... in the U.S., Hoge said Moderna is engaging closely with the FDA to ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

The FDA has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.